The 313-SNP PRS was associated with both female and male BC risk in BRCA PV carriers, suggesting that risk profiling on the basis of PRS may provide a further individual cancer risk stratification for carriers of BRCA1/2 PVs, with implications for their clinical management [173,174]. This evidence concerns the gene BRCA1 and cancer.